Oncology Therapeutic Pharmaceutical Candidates
BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The company's pipeline currently consists of BL-8040, a platform for multiple cancer and hematological indications; and AGI-134, a synthetic immunotherapy in development for solid tumors. The BioLineRx pipeline is generated by systematically identifying, validating, and in-licensin…